Senzime AB AB (publ), a company listed on Nasdaq Stockholm that develops and markets CE- and FDA-cleared monitoring systems for patients undergoing anesthesia, has carried out a directed issue of shares raising the company gross proceeds of SEK 100 million. Carnegie Investment Bank acted financial advisor in connection with the directed issue.
The subscription price was determined through an accelerated book building process.
Lindahl's team consisted of Mattias Prage, Andreas Mellberg and Michaela Larsson.
